DaxibotulinumtoxinA for Injection

daxibotulinumtoxinA · Revance Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for DaxibotulinumtoxinA for Injection, covering 2019-11-06 to 2024-04-03. Get the full timeline:

Most recent: Clinical Trial Update: DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis [Phase 2]